Pharmagreen Biotech Inc. reported earnings results for the second quarter and six months ended March 31, 2024. For the second quarter, the company reported sales was USD 0.001058 million compared to.
CARSON CITY, NV / ACCESSWIRE / January 24, 2024 / Pharmagreen Biotech, Inc., (OTC PINK:PHBI), "Pharmagreen" or the "Company" is pleased to announce the signing of a supply agreement with
CARSON CITY, NV / ACCESSWIRE / January 24, 2024 / Pharmagreen Biotech, Inc., (OTC PINK:PHBI), "Pharmagreen" or the "Company" is pleased to announce the signing of a supply agreement with SierraSil® Health Inc., a manufacturer specializing in a proprietary natural hydrothermal mineral complex known as SierraSil®. This patented mineral complex, developed by SierraSil® Health Inc., adheres to rigorous standards is supported by two US patents and extensive clinical research. Pharmagreen has secured
CARSON CITY, NV, Nov. 29, 2022 via NewMediaWire – Pharmagreen Biotech, Inc., is pleased to announce that Mr. Tyrell Crosby, a professional NFL player, has joined the Pharmagreen team to. | November 29, 2022